Royce & Associates’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-75,261
| Closed | -$3.03M | – | 867 |
|
|
2024
Q4 | $3.03M | Buy |
75,261
+61,927
| +464% | +$2.49M | 0.03% | 565 |
|
|
2024
Q3 | $844K | Buy |
+13,334
| New | +$844K | 0.01% | 746 |
|
|
2024
Q2 | – | Sell |
-6,951
| Closed | -$570K | – | 916 |
|
|
2024
Q1 | $570K | Sell |
6,951
-21,086
| -75% | -$1.73M | 0.01% | 780 |
|
|
2023
Q4 | $522K | Buy |
+28,037
| New | +$522K | ﹤0.01% | 790 |
|
|
2019
Q1 | – | Sell |
-135,000
| Closed | -$1.03M | – | 1190 |
|
|
2018
Q4 | $1.03M | Buy |
+135,000
| New | +$1.03M | 0.01% | 853 |
|